ELREXFIO
ELREXFIO
Approved
DIN Number
02543567
Drug Class
Human
Market Date
Jan 23, 2024
Company
HC
Pfizer Canada Ulc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02543567
AIG Number0165382001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
,
Prescription
A
ATC Code
L01FX32 ELRANATAMAB
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
AHFS Classification10:00.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
ELRANATAMABActive
Strength: 76 MG / 1.9 ML
Monograph: ELRANATAMAB